Earnings · US stocks

Oruka Therapeutics, Inc. (ORKA) earnings

Oruka Therapeutics, Inc. published its quarterly report on 2026-11-09. The stock moved +0.41% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-09
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+4.72%—
3 days+0.41%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 3 of them. The stock rose in the 3 trading days after 6 of 8 reports (average +7.66%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-09-0.63-0.61%+0.41%——
2026-08-10-0.55-9.95%+8.68%-5.50%-5.54%
2026-05-13-0.48+10.61%-7.66%+43.40%+45.19%
2026-03-12-0.45+26.89%+29.13%+115.79%+108.60%
2025-11-12-0.55-4.96%-0.25%+12.01%+11.00%
2025-08-11-0.46-6.36%+14.94%+19.23%+14.94%
2025-05-14-0.40+9.09%+6.18%+14.11%+9.46%
2025-03-06-0.49-18.55%+9.83%-8.44%-0.36%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: ORKA

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.